Search Results

Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, has been recognized with a Distinguished Abstract Award for their abstract entitled “Analytical and clinical performance of a novel ovarian cancer screening test in asymptomatic women.”

The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park.

Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting showing the performance of its Mercy Halo™ Ovarian Cancer screening test in a large cohort of asymptomatic, postmenopausal women.

Mercy BioAnalytics, Inc. will present data at the American Society of Clinical Oncology Annual Meeting next month demonstrating the first significant improvement in the early detection of ovarian cancer using a locked assay since CA125 serum biomarker testing and transvaginal ultrasound imaging were introduced nearly 40 years ago.

Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, launch a new assay for quantifying pharmacodynamic markers of radioligand therapies in tumors.

Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).

Resolian, a global bioanalytical contract research organization specializing in drug metabolism and pharmacokinetics for small and large molecules, has acquired Denali Medpharma, a leading China-based bioanalytical CRO.

The global bioanalytical testing services market size is projected to surpass around USD 10.39 billion by 2032, increasing form USD 4.78 billion in 2023 with a remarkable CAGR of 9.02% from 2023 to 2032.